Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair by Fergie, Nicola et al.
Hypercapnic acidosis induces mitochondrial dysfunction and impairs
the ability of mesenchymal stem cells to promote distal lung epithelial
repair
Fergie, N., Todd, N., McClements, L., McAuley, D., O'Kane, C., & Krasnodembskaya, A. (2019). Hypercapnic
acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal
lung epithelial repair. The FASEB Journal. https://doi.org/10.1096/fj.201802056R
Published in:
The FASEB Journal
Document Version:
Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© 2019 The Authors.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0)
(http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:05. Apr. 2019
THE
JOURNAL • RESEARCH • www.fasebj.org
Hypercapnic acidosis induces mitochondrial dysfunction
and impairs the ability of mesenchymal stem cells to
promote distal lung epithelial repair
Nicola Fergie, Naomi Todd, Lana McClements, Danny McAuley, Cecilia O’Kane,
and Anna Krasnodembskaya1
Centre for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen’s University of Belfast, Belfast, United
Kingdom
ABSTRACT: Acute respiratory distress syndrome (ARDS) is a devastating disorder characterized by diffuse inflammation
and edema formation. The main management strategy, low tidal volume ventilation, can be associated with the devel-
opment ofhypercapnic acidosis (HCA).Mesenchymal stemcells (MSCs) are apromising therapeutic candidate currently
in early-phase clinical trials. The effects of HCA on the alveolar epithelium and capillary endothelium are not well
established. The therapeutic efficacy ofMSCs has never been reported in HCA. In the present study, we evaluated the
effectsofHCAoninflammatoryresponseandreparativepotentialof theprimaryhumansmallairwayepithelialandlung
microvasculatureendothelialcellsaswellasonthecapacityofbonemarrow2derivedMSCstopromotewoundhealing in
vitro.Wedemonstrate thatHCAattenuates the inflammatory response and reparative potential of primary human small
airway epithelium and capillary endothelium and inducesmitochondrial dysfunction. It was found thatMSCs promote
lungepithelialwoundrepairvia thetransferoffunctionalmitochondria;however, thisproreparativeeffectofMSCswaslostin
the settingofHCA.Therefore,HCAmayadversely impact recovery fromARDSat the cellular level,whereasMSCsmaynot
betherapeuticallybeneficialinpatientswithARDSwhodevelopHCA.—Fergie,N.,Todd,N.,McClements,L.,McAuley,D.,
O’Kane, C., Krasnodembskaya, A.Hypercapnic acidosis inducesmitochondrial dysfunction and impairs the ability of
mesenchymal stem cells to promote distal lung epithelial repair. FASEB J. 33, 000–000 (2019). www.fasebj.org
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Acute respiratory distress syndrome (ARDS) is an acute in-
flammatory disorder in which the integrity of the alveolar
epithelial2capillary endothelial barrier is compromised and
protein-rich alveolar edema accumulates. Low tidal volume
ventilation is the mainstay of treatment, but it can be asso-
ciatedwith the development of hypercapnic acidosis (HCA)
(1, 2).Althoughsecondaryanalysisof clinicaldata suggested
that HCA may reduce mortality in ARDS (3), data from
preclinical models are controversial.
The pulmonary capillary endothelium and alveolar epi-
thelium contribute to inflammation in ARDS by promoting
alveolar neutrophil recruitment. In addition, disruption to
the integrity of the endothelial-epithelial barrier contributes
to the accumulation of pulmonary edema. The response of
these endothelial and epithelial cells to HCAmay therefore
have profound implications for the resolution of ARDS.
Todate, only 2 studies have reported the effects ofHCA
on endothelia. These studies have highlighted conflicting
results; whereas Takeshita et al. (4) reported attenuation of
inflammation by HCA, Liu et al. (5) demonstrated that
HCA enhances inflammatory responses. It is noteworthy
that Takeshita et al.modeled the endothelium using mac-
rovascular human pulmonary artery endothelial cells,
whereas Liu et al. utilized human pulmonary microvas-
cular endothelial cells (HPMECs). Significant heterogene-
ity exists between macrovascular and microvascular cells
with regard to protein expression profiles and barrier
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function (6–10). The use of human pulmonary artery en-
dothelial cells to study the pulmonary capillary endothe-
lium may therefore limit the translational value of the
results obtained. Furthermore, although HPMECs are the
most relevant cell type in the context ofARDS, in the study
byLiu et al., the invitro resultswere corroboratedbydata in
a rabbit model of LPS-induced lung injury in which
endothelial-neutrophil responses were significantly in-
creased during hypercapnia (5). These data contradict
previous in vivo findings in the models of sepsis- and
paraquat-induced lung injury in rats, demonstrating an
immunosuppressive effect of HCA (11, 12).
Although several studies reported thatHCAattenuates
the contribution of the alveolar epithelium to inflam-
mation (13, 14)—an effect that would be beneficial in
ARDS—other in vitro research indicates that it may also
attenuate wound closure (15) and alveolar fluid clearance
(16–20), suggesting impaired potential for alveolar re-
epithelialization and the resolution of pulmonary edema.
However, much of this work was performed in the ade-
nocarcinomic human alveolar basal epithelial cell line
A549. Although generally considered representative of
the alveolar epithelium, concerns exist regarding the con-
sistency of the A549 phenotype compared with that of
primary human alveolar epithelial cells (21–26). Results
obtained inA549 cells should therefore be interpretedwith
caution until confirmed in primary cells.
Although no pharmacological therapy has been suc-
cessful in treating ARDS (27), mesenchymal stem cells
(MSCs) show promising therapeutic potential against
inflammation and pulmonary edema in preclinical models
(28–31). These effects may be mediated by the secretion
of paracrine mediators (32–34) or via transfer of mito-
chondria to injured cells (35, 36). MSCs have entered
early-phase clinical trials, which to date attest to their
safety in ARDS (37–39). However, although known to
respond to their local environment, the effects ofHCAon
MSC biology and therapeutic potential have never been
reported.
The aims of the present work were as follows: 1) de-
termine the effect of HCA on the inflammatory and re-
parative responses of the human capillary endothelium
andalveolar epithelium, 2) determine the effect ofHCAon
the biologic properties and therapeutic capacity of MSCs,
and 3) elucidate the mechanisms of these effects. Some of
the results of these studieswere previously reported in the
form of an abstract (40).
MATERIALS AND METHODS
Cell culture
HPMECs and human small airway epithelial cells (SAECs) (both
from PromoCell, Heidelberg, Germany) were maintained in en-
dothelial cell growth medium MV and SAEC growth medium
(PromoCell), respectively.Eachmediumwassupplementedwith
50 mg/ml penicillin-streptomycin (PS) (Thermo Fisher Scientific,
Waltham, MA). Both cell types were used to passage 7. Human
bonemarrow2derivedMSCsmet the criteria of the International
Society for Cellular Therapy (41) and were obtained from the
Institute forRegenerativeMedicineatTexasA&MHealthScience
Center (Temple, TX, USA). MSCs were maintained in minimum
essential medium with alpha modifications (a-MEM) (Thermo
Fisher Scientific) supplementedwith 16.5%heat-inactivated fetal
bovine serum (FBS), 50 mg/ml PS, and 4 mM L-glutamine (LG)
(Thermo Fisher Scientific) and were used to passage 5.
Induction of HCA
Conditions of normocapnia and HCA were achieved using
Panasonic (Osaka, Japan) MCO-230AIC CO2 incubators, with
CO2 set to 5 and 15%, respectively. Media used for experimen-
tation were pre-equilibrated in the absence of cells in T25 cell
culture flasks under these conditions overnight. pH and partial
pressure of CO2 (pCO2)were analyzed using a cobas b 221 blood
gas analyzer (Roche, Basel, Switzerland).
Inflammatory stimulation of cells
Unless otherwise stated, HPMECs or SAECs were seeded at a
density of 13 104 cells/cm2 andallowed to reach 80%confluence
in 5% CO2 prior to use for experimentation. Media were then
removed, and the cellswerewashedwithDulbecco’s phosphate-
buffered saline (DPBS). For experimentation, cells were stim-
ulated with a cytomix of proinflammatory cytokines. This
cytomix was prepared separately in pre-equilibrated cell culture
media for cells to be exposed to normocapnia and for cells to be
exposed to HCA. The cytomix contained TNF-a (Peprotech,
Rocky Hill, NJ, USA), IL-1b (Peprotech), and IFN-g (R&D Sys-
tems,Minneapolis,MN,USA), eachataconcentrationof50ng/ml.
Stimulated cells were subsequently cultured in either 5% CO2
(normocapnia; pCO2 3.46 0.1 kPa andpH7.3) or 15%CO2 (HCA;
pCO29.060.2kPaandpH7.0) for thedurationofeachexperiment.
Unlessotherwisestated,HPMECsandSAECswereexposed to5or
15% CO2 with or without cytomix for 72 and 24 h, respectively,
before analyseswere performed. In contrast,MSCswere seeded in
the presence or absence of cytomix and cultured immediately in
5 or 15% CO2 at the time of seeding. For experiments in which
MSCswere the sole cell type used, cellswere seeded at a density of
23104cells/cm2andanalyseswereperformedafter24-hculture in
5 or 15% CO2 with or without cytomix.
Coculture experiments
For coculture experiments, MSCs were seeded on Transwell
inserts (Greiner Bio-One, Kremsmu¨nster, Austria) at a ratio
of 1:5 MSC:SAECs. SAECs had been seeded at a density of
13 104 cells/cm2 and allowed to reach 80% confluence in 5%
CO2. Medium was then aspirated, and the cells were washed
with DPBS before the addition of MSCs. Cytomix stimulation
was applied to both the upper and lower chambers at the time
of MSC seeding. The coculture was then immediately in-
cubated in 5 or 15% CO2 for 24 h before analyses were
performed.
Quantification of cytokines and growth factors
by ELISA
Commercially available DuoSet Sandwich ELISAs (R&D Sys-
tems) were used to measure human C-X-C motif chemokine li-
gand (CXCL)8, CXCL5, angiopoietin-1 (Ang-1), keratinocyte
growth factor, IL-1 receptor antagonist (IL-1ra), and IL-10 con-
centrations in cell-free supernatants. All assays were performed
following the manufacturer’s standard instructions for DuoSet
ELISAs.Working concentrations of the antibodies providedwith
each kit were analyte and lot specific.
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Evaluation of endothelial adhesion molecule
expression by HPMECs
Flowcytometrywasused toassess theeffectsofHCAonHPMEC
expression of the adhesion molecules endothelial-selectin
(E-selectin), intercellular adhesion molecule (ICAM)-1, and
VCAM-1.
After 72 h incubation in the presence or absence of 50 ng/ml
cytomix, HPMEC monolayers were washed with 1 ml 13 PBS,
and the cells were gently scraped, transferred into 5-ml poly-
styrene flow tubes (Sarstedt; Thermo Fisher Scientific), and
centrifuged for 5 min at 800 rpm and 4°C. The supernatant was
aspirated off, and the pellet resuspended in 200 ml 13 PBS. To
prevent non-specific binding of antibodies, 20 ml human Fc Re-
ceptor binding inhibitor (Thermo Fisher Scientific) was added
and incubated with the cells on ice for 20 min. Appropriate
antibodies directed against the proteins of interest (Table 1)
were added to the experimental groups and incubated on ice
for 30min in the dark. Unstained controls, isotype controls for
each fluorophore used, and single-stain controls for each
fluorophore were also included. Samples were immediately
processed using a FACSCanto II flow cytometer and FACS-
Diva software (BD Biosciences, San Jose, CA, USA). If neces-
sary, compensation was set up using FACSDiva between 2
fluorophores based on overlap in the single-stain controls. All
data were analyzed using FlowJo v.10 software (FlowJo; BD
Biosciences, San Jose, CA, USA).
In vitro wound scratch assay
An in vitrowound scratch assay was used to assess the effects of
HCA on epithelial and endothelial wound repair. Horizontal
lines were created across the undersurface of the wells of 24-well
plates prior to cell seeding. HPMECs or SAECs were seeded on
these plates at a density of 1 3 104 cells/cm2 and cultured until
monolayer formation occurred. At this point, a single vertical
scratchwoundwasmade from the top to the bottomof eachwell,
running through the horizontal line, using a P1000 pipette tip
(Sarstedt,Nu¨mbrecht,Germany). The edge of a rulerwasused to
guide a straight line. Cells were washed twice with DPBS to
remove cell debris, and 500 ml 1% supplemented medium (see
negative control in Table 2) was added to each of the wells. The
wound sites were imaged at310 magnification using the Axio-
vert 25 inverted light microscope (Carl Zeiss, Oberkochen, Ger-
many) and AxioVision Release 4.8 software (Carl Zeiss). Two
images were taken from each well; 1 was taken just above the
horizontal line and 1 just below it to allow for re-imaging of the
same area of each wound later in the experiment. To limit bias
when calculating wound closure, each of the conditions was
blinded by an independent researcher unrelated to the project
prior to its addition to the cells. Wounded cells, regardless of cell
type,were incubatedunder appropriate experimental conditions
for 24 h at 37°C in either 5 or 15% CO2.
Wounds were re-imaged as before in the same areas as the
baseline wounds following 24 h incubation. ImageJ v.1.48 (Na-
tional Institutes of Health, Bethesda, MA, USA) was used to
measure the area of the wound site at baseline and again at 24 h.
The percentage wound closure at 24 hwas calculated from these
values. Only at this stage were the conditions un-blinded to
permit interpretation of the results.
Determination of cell viability by lactate
dehydrogenase assay
The commercially available Cytotoxicity Detection Kit (Roche),
which is based on the activity of lactate dehydrogenase (LDH) in
cell-free supernatants, was used to assess the impact of HCA on
HPMEC, SAEC, and MSC cell death in both inflammatory and
noninflammatory environments.
At 24, 48, or 72 h post-stimulation of cells with cytomix, cell
supernatants were collected and centrifuged to remove cell de-
bris. A positive control was included in which cells were lysed
with a final concentration of 2% Triton X-100 (MilliporeSigma,
Burlington, MA, USA) 10 min before the collection of superna-
tants. Fifty-microliter samples were plated in triplicate into a 96-
well plate (Nunc; Thermo Fisher Scientific). Optical densities
were measured at 405 nm using a Fluostar Omega (BMG Lab-
tech, Ortenberg, Germany) microplate reader. Data were ana-
lyzed usingMars data analysis software (BMGLabtech). Results
are presented relative to the positive control.
NF-kB activation
Stimulation of cells
MSCswere seededon6-well plates at a density of 23 105 cells per
well and allowed to adhere overnight ina-MEM16.5% FBS + PS + LG.
HPMECs or SAECswere seeded on 6-well plates at a density of 1
3 105 cells per well and cultured in their respective cell culture
medium until monolayer formation was achieved. On the day of
experimentation, the cells were washed with 1 ml prewarmed
DPBS, which was immediately aspirated off. Two milliliters
a-MEM1% FBS + PS + LG, which had been pre-equilibrated in 5 or
15%CO2overnight,wasaddedto theMSCs,andthecellswere left
to rest for 2 h in 5 or 15%CO2 at 37°C because of the sensitivity of
NF-kB activation. For HPMECs or SAECs, their respective cell
culture mediumwas used. After incubation, 100 ml mediumwas
removed from each well. Cytomix was prepared to a concentra-
tion of 1 mg/ml in pre-equilibrated a-MEM1% FBS + PS + LG for
MSCs or cell culturedmedium forHPMECs and SAEC.A total of
100mlwas added to the 1.9mlmediumalready in the appropriate
wells, bringing the final concentration to 50 ng/ml. For un-
stimulated cells and for the 0-min control, 100 ml of only pre-
equilibratedmediumwas added instead of cytomix. The plates
were incubated at 37°C and either 5 or 15% CO2 for 0, 30, or
60 min. At the end of each incubation period, the medium was
aspirated from the wells, and the cells were scraped from the
surface in 1 ml ice-cold PBS. Replicate cell suspensions of each
condition were pooled and kept on ice in preparation for nu-
clear extraction.
Preparation of nuclear extracts
Nuclear extracts were prepared from chilled cell suspensions
using theNE-PERNuclear andCytoplasmic ExtractionReagents
TABLE 1. Antibodies used to assess HPMEC adhesion molecule expression by ﬂow cytometry
Protein of interest Fluorophore Manufacturer Dilution
Anti-human CD62E (E-selectin) APC BioLegend 1:100
Anti-human CD54 (ICAM-1) FITC BioLegend 1:100
Anti-human CD106 (VCAM-1) PE BioLegend 1:100
APC, Allophycocyanin; CD, cluster of differentiation; PE, Phycoerythrin.
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Kit (Thermo Fisher Scientific), following the manufacturer’s in-
structions. Briefly, the cells were pelleted by centrifugation at
800 g for 3 min at 4°C, and the supernatant was discarded. The
cell pellet was resuspended in 200 ml Cytoplasmic Extraction
Reagent I containingHalt protease inhibitor cocktail (EDTA-free)
(ThermoFisher Scientific), vortexed, and incubated for 10min on
icebefore theadditionof 11mlCytoplasmicExtractionReagent II.
Sampleswerevortexed at thehighest setting for 5 s, incubated on
ice for 1min, andvortexed againbefore centrifugation at 16,000 g
for 5 min at 4°C. Supernatants containing cytoplasmic extracts
were collected into ice-coldEppendorf tubes andkept on ice until
the end of the extraction protocol.
The insoluble pellet was resuspended in 100 ml ice-cold Nu-
clear Extraction Reagent containing Halt protease inhibitor
cocktail (EDTA-free) and vortexed at the highest setting for 15 s.
Sampleswere incubatedon ice for 40min,with thevortexingstep
repeated every 10 min until the time was up. Supernatants con-
taining the nuclear extracts were collected into fresh, ice-cold
Eppendorf tubes immediately following centrifugation of the
samples at 16,000 g for 10 min at 4°C. All extracts were stored at
280°C for future use.
Protein quantification
Protein concentrations in nuclear extracts were quantified using
the Coomassie (Bradford) Protein Assay Kit (Thermo Fisher
Scientific). Bovine serum albumin (BSA) standards ranging in
concentration from0 to 2000mg/mlwere prepared following the
manufacturer’s instructions. A total of 5 ml of each standard or
samplewas pipetted in duplicate into thewells of a 96-well plate
followedby250ml Coomassie reagent.Well contentsweremixed
on a plate shaker for 30 s, and the plate was incubated at room
temperature for 5 min, protected from light. Absorbance was
measured at 595 nm using a Fluostar Omega microplate reader,
and the concentration of protein in each unknown sample was
extrapolated from a second polynomial curve generated using
Mars data analysis software.
TransAM NF-kB p65 assay
The TransAMNF-kBp65AssayKit (ActiveMotif, Carlsbad, CA,
USA) is a DNA-binding ELISA that facilitates the detection of
activeNF-kBp65 subunits innuclear extracts. In this assay, active
p65 subunits bind to their consensus oligonucleotides, which
have been immobilized on a 96-well plate supplied with the kit.
Boundsubunits canbedetected thereafter inaprinciple similar to
that of an ELISA. This assay was used, following the manufac-
turer’s instructions, to detect active p65 subunits in the nuclear
extracts of HPMECs, SAECs, or MSCs cultured in 5 or 15% CO2.
Nuclear extracts were diluted in complete lysis buffer to a
protein concentration of 150mg/ml (forMSCs) or 100mg/ml (for
HPMECs or SAECs). Jurkat extract (positive control supplied
with the kit) was also diluted to a protein concentration of 125 or
100mg/ml in complete lysis buffer.A total of 30ml complete lysis
buffer was added to the wells of the 96-well plate supplied fol-
lowed by 20 ml Jurkat extract or unknown sample (containing 3
mg protein forMSCs or 2mg protein forHPMECs and SAECs). A
total of 20 ml complete lysis buffer was included as a blank con-
trol, and theplatewas incubatedat roomtemperature for1hwith
mild agitation from a plate rocker. The plate waswashed 3 times
using the wash buffer supplied with the kit and gently blotted
against paper towels to dry. Primary antibody (rabbit anti2NF-
kB p65) was diluted 1:1000, and 100 ml was added per well. The
platewas incubated at room temperature for 1 h in the absence of
agitation from a plate rocker. The wash step was repeated and
100ml Horseradish Peroxidase-conjugated anti-rabbit secondary
antibody (diluted 1:1000) was added per well. The plate was
incubated again for 1 h at room temperature without agitation.
Thewash stepwas repeated 4 times. A total of 100ml developing
solutionwas added perwell and incubated at room temperature
protected fromlightuntil the colorof the samplewellshad turned
medium-to-dark blue. A total of 100 ml stop solution was added
to stop the reaction, and the optical densitywasmeasuredwithin
5 min at 450 nm using a Fluostar Omega plate reader.
Assessment of mitochondrial function
Measurement of mitochondrial membrane
potential using 5,59,6,69-tetrachloro-1,19,3,
39-tetraethylbenzimidazolylcarbocyanine iodide dye
5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazolylcarbocya-
nine iodide (JC-1) is a lipophilic, cationic dye that accumulates
within mitochondria in a manner dependent on mitochondrial
membrane potential. When mitochondrial membrane potential
is low, JC-1 accumulates within mitochondria in low concentra-
tions and persists in a monomeric form, fluorescing green. At
higher mitochondrial membrane potential, JC-1 accumulation
within themitochondria is increased. Red fluorescing aggregates
begin to form. A higher red/green fluorescence ratio is therefore
proportional to mitochondrial membrane potential. JC-1 was
used to assess the impact of HCA on mitochondrial membrane
potential in HPMECs, SAECs, and MSCs under both in-
flammatory and noninflammatory conditions.
After 24 h of cytomix stimulation and culture in 5 or 15%CO2,
cells were stained with JC-1 (Thermo Fisher Scientific) at a con-
centration of 0.5mg/ml for 45min (SAECs) or 1 h (HPMECs and
MSCs). A control was included in which 1 mM carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCCP) (MilliporeSigma)
was simultaneously added to the cells at the time of JC-1 staining
to induce mitochondrial depolarization (collapse of mitochon-
drial membrane potential). Following staining, wells were
washed 3 times using 13 PBS. A total of 100 ml 13 PBS was
added per well. Live cells were immediately imaged at 320
magnification using the EVOS FL Auto epifluorescent micro-
scope (Thermo Fisher Scientific). Red and green fluorescence
TABLE 2. Conditions added to wounded HPMECs and SAECs
Conditions
HPMEC (Endothelial cell
growth medium MV) SAEC medium
Vehicle 10% supplemented 10% supplemented
Cytomix 50 ng/ml cytomix (TNF-a, IL-1b,
IFN-g) in vehicle
50 ng/ml cytomix (TNF-a, IFN-g)
in vehicle
Negative control 1% supplemented 1% supplemented
Positive control 100% supplemented 100% supplemented
Percentage supplement refers to the percentage of the supplement added to the standard culture
medium for each cell type.
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intensity of each image was measured using ImageJ v.1.48, and
the red/green ratio was calculated.
JC-1 staining of MSCs cultured in buffered hypercapnia
In some experiments, acidosis was buffered to facilitate the de-
termination of the individual contributions of pHandCO2 to the
effects of HCA, particularly its effects on mitochondrial mem-
brane potential of MSCs. The experimental setup was done as in
previous experiments, with both un-stimulated or cytomix-
stimulated MSCs being cultured in 5 or 15% CO2 for 24 h.
However, in this case, an additional 2 groups (1 un-stimulated
and 1 cytomix-stimulated) in which the pH was buffered to that
observed in 5% CO2 were included in 15% CO2. This was
achieved using pre-equilibrated medium that contained 0.02 M
sodium bicarbonate (NaHCO3) (MilliporeSigma). A total of
0.02Msodiumchloride (NaCl) (MilliporeSigma)prepared inpre-
equilibratedmediumwas added to all other groups in both 5 and
15%CO2 to ensure all groupswere equiosmolar. Cells were then
cultured in 5 or 15% CO2 for 24 h prior to JC-1 staining as pre-
viously described in the cell culture section.
ATP assay
The majority of cellular ATP originates from the mitochondrial
electron transport chain. ATP production is therefore indicative
of mitochondrial function. Intracellular ATP levels were mea-
sured after culture of MSCs in the presence or absence of 50 ng/
ml cytomix for 24 h using a luminescent ATP detection assay kit
(Abcam, Cambridge, United Kingdom), following the manu-
facturer’s instructions. All reagents were brought to room tem-
perature prior to use. Fifty microliters supplied detergent was
added to each well containing the conditions of interest and to
eachwell containing only 90mla-MEM1% + PS + LG in preparation
for a standard curve. The plate was incubated at room temper-
ature on an orbital shaker for 5 min. Standards ranging in con-
centration from 10 mM to 0.1 nMwere prepared. Ten microliters
prepared standardwasadded to90mla-MEM1%+ PS + LGalready
in the wells reserved for the standard curve. The plate was in-
cubated at room temperature for 5min on an orbital shaker. Fifty
microliters of the supplied substrate solutionwas then addedper
well. The plate was incubated again at room temperature for 5
min on an orbital shaker. Luminescence was measured imme-
diately using a Fluostar Omega microplate reader.
Coculture experiments
Mitochondrial transfer
MitoTracker dyes (Thermo Fisher Scientific) are cell-permeable
probes that react with the thiol groups of, and thus label, mito-
chondria. To investigate whether mitochondria are transferred
from MSCs to SAECs, MSCs were stained with 125 ng/ml
MitoTracker Green FM (Thermo Fisher Scientific) for 45 min at
37°C in 5% CO2. SAECs were prestained with 125 ng/ml Mito-
TrackerDeepRed (Thermo Fisher Scientific) for 1 h at 37°C in 5%
CO2. Stained cellswerewashed3 timeswith 13PBS.A sample of
the third MSC wash was retained for use as a leak control. Pre-
stained MSCs were seeded on Transwell inserts with 0.4-mm
pores (Greiner Bio-One) at a ratio of 1MSC to every 5 SAECs and
cocultured for 24 h in 5 or 15% CO2 in the presence of 50 ng/ml
cytomix with prestained SAECs seeded on the well surface be-
low. For the leak control, MSCs were replaced with an equal
volume of the MSC wash retained earlier.
After 24 h, the Transwellswere removed and the SAECswere
washed 3 timeswith PBS. Live SAECswere immediately imaged
at 320 magnification on an EVOS FL Auto epifluorescence
microscope to visualize MSC-derived green mitochondria up-
take by SAECs.
Coculture in vitro scratch assay
To assess the effects of MSCs on SAEC wound closure in nor-
mocapnia andHCA,MSCswere cocultured on Transwell inserts
(Greiner Bio-One) with SAECs as previously described in the
coculture experiments section. SAECs were wounded in an in
vitro scratch assay. Plateswere incubated at 37°C in 5 or 15%CO2
for 24 h.At 24h, Transwell insertswere removed, and thewound
areas above and below the horizontal lines were re-imaged. The
area of the wound site at baseline and 24 h was measured using
ImageJ v.1.48. The values obtained were used to calculate the
percentage wound closure over 24 h.
Ki67 staining
Ki67 is a cellular marker of proliferation. SAECs wounded in an
in vitro scratch assay and cocultured with MSCs were immuno-
fluorescently stained for this marker. SAECs were washed 3
timeswith 13PBS and fixedwith 4%paraformaldehyde at room
temperature for 15min.Excessparaformaldehydewasaspirated,
and the wash step was repeated. Cells were permeabilized by
incubation with 0.5% Triton X-100 for 20 min at room tempera-
ture. Thewash stepwas repeated.Cellswereblockedwith 200ml
1% BSA (prepared in 13 PBS) for 2 h at room temperature. The
wash step was repeated. The primary antibody Ki67 mAb
(SolA15) (Thermo Fisher Scientific) was diluted 1:200 in 1% BSA.
One hundred microliters primary antibody was added per well
and incubated at 4°C overnight. For a secondary-only control,
100 ml 1% BSA only was added.
Afterovernight incubation, cellswerewashed3 timeswith13
PBS. Goat anti-mouse/rat Alexa Fluor 594 was diluted 1:200 in
1% BSA. One hundred microliters was added per well and in-
cubated in the dark for 1 h at room temperature. For a primary-
only control, 100 ml 1% BSA only was used. The wash step was
repeated. One hundred microliters Hoechst nuclear stain (un-
diluted) (MilliporeSigma) was added per well and incubated in
the dark at room temperature for 20 min. The wash step was
repeated. Two hundred microliters 13 PBS was added to the
wells and the plateswere stored at 4°C in the dark until imaging.
Images were taken at 35 magnification using a Leica DMi8
microscope (Leica Microsystems, Wetzlar, Germany). One image
was taken above and 1 below the horizontal line running across the
undersurface of the wells. To quantify Ki67 staining, a grid of indi-
vidual squares each of 100,000 pixels2 in size was drawn over each
imageusingImageJv.1.48.Fourwellsat theedgeof thewoundwere
selected fromeach image, and thenumber of cells stainedpositively
for Ki67 were counted using the multipoint tool. The average
number of Ki67-positive cells per 100,000 pixels2 was determined.
Loss-of-function experiment
A loss-of-function experiment was performed to determine the
contribution of mitochondria to the ability of MSCs to promote
SAEC wound closure in normocapnia. To induce mitochondrial
dysfunction, confluent MSCs were treated with 1 mg/ml rhoda-
mine 6G (R6G) (MilliporeSigma)prepared ina-MEM16.5% + PS + LG
for 48 h at 37°C in 5% CO2. Medium was supplemented with
50mg/ml uridine (MilliporeSigma) and 2.5mMsodiumpyruvate
(MilliporeSigma) to support glycolysis. At the same time, the
medium in another flask of MSCs at the same passage and con-
fluence was replaced with fresh a-MEM16.5% + PS + LG. After 48 h,
the media were aspirated from both flasks of MSCs, and the cells
were washed 3 times with PBS. The MSCs were trypsinized and
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counted. The in vitro scratch assay was repeated, including an
additional group in normocapnia in which R6G-treated MSCs
were cocultured with SAECs.
Statistical analysis
GraphPad Prism v.5.01 (GraphPad Software, La Jolla, CA, USA)
was used to perform statistical analysis. One-way ANOVAwith
Bonferroni post hoc analysis was used to analyze parametric data.
Kruskal-Wallis with Dunn’s post hoc analysis was used for non-
parametric data. Groupeddatawere analyzed by 2-wayANOVA.
Values of P, 0.05 were regarded as statistically significant.
RESULTS
HCA attenuates the inflammatory response
of HPMECs and SAECs
To mimic the inflammatory environment of ARDS, en-
dothelial and epithelial cells were stimulated with a pro-
inflammatory cytokinemixture (IL-1b, INF-g, andTNF-a)
and cultured in either 5%CO2 (normocapnia) or 15%CO2
(HCA). The effects ofHCAon both cell typeswere similar.
HCA did not affect the viability of HPMECs for at least
72 h (Fig. 1A). At 72 h,HCA significantly attenuated levels
of HPMEC secretion of the neutrophil chemoattractants
CXCL8 andCXCL5 (Fig. 1B, C) and the level of expression
of neutrophil adhesionmolecule ICAM-1 [asmeasured by
median fluorescence intensity (MFI)] (Fig. 1D). No differ-
ences were observed in the percentage of cells expressing
neutrophiladhesionmoleculesE-selectinorVCAM-1or inthe
degree of expression per cell (Supplemental Fig. S1). As with
HPMECs, viability of SAECs remainedunaltered inHCAup
to 72 h (Fig. 1E), whereas levels of CXCL8 and CXCL5 se-
cretion were significantly decreased at 24 h (Fig. 1F, G).
HCA attenuates wound repair by HPMECs
and SAECs
In vitro wound scratch assays revealed that HCA signifi-
cantly impairs HPMEC and SAEC wound closure at 24 h
in a noninflammatory setting (Fig. 2). When stimulated
with cytomix, HPMEC wound closure was almost com-
pletely inhibited under both conditions (Fig. 2A). Simi-
larly, SAEC wound closure was also diminished by
cytomix stimulation in normocapnia, whereas a non-
significant trend toward further worsening of the re-
parative response was observed in HCA (Fig. 2B).
HCA does not alter the degree of NF-kB
activation but impairs mitochondrial function
It has been previously demonstrated that HCA attenuates
the inflammatory responses of A549 cells through in-
hibition ofNF-kB activation (14). To probe themechanism
behind the observed effects of HCA on HPMECs and
SAECs, the degree of NF-kB activation was assessed by
p65 TransAM assay, a DNA-binding ELISA by which
consensus oligonucleotides are used to detect the presence
Figure 1. HCA attenuates the inﬂammatory response of HPMECs and SAECs. A) HCA did not alter HPMEC cell viability at 72 h
when assessed by measurement of LDH release. B) HCA attenuated HPMEC secretion of the neutrophil chemoattractant CXCL8
at 72 h when measured by ELISA. C) HCA attenuated HPMEC secretion of the neutrophil chemoattractant CXCL5 at 72 h when
measured by ELISA. D) HCA reduced HPMEC expression of the neutrophil adhesion molecule ICAM-1 at 72 h. This was
reﬂected in the MFI when analyzed by ﬂow cytometry. E) HCA did not alter SAEC viability at 24 h. F) HCA attenuated SAEC
secretion of CXCL8 at 24 h. G) HCA attenuated SAEC secretion of CXCL5 at 24 h. +ve Ctrl, positive control. Scatter plots show
means and SDs. n = 5 per group for all experiments. *P , 0.05, **P , 0.01, ***P , 0.001.
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of active NF-kB p65 subunits in nuclear extracts. In-
terestingly, in both cell types, the degree of NF-kB activa-
tion was not altered by HCA (Fig. 3A, B).
Mitochondrial dysfunction has been reported as an al-
ternative mechanism involved in the HCA effects. Specifi-
cally, it was associated with impaired proliferation of A549
cells (42). The effect of HCA on mitochondrial membrane
potential was therefore investigated. Staining of both cell
typeswith themitochondrial membrane potential indicator
JC-1 revealed significant attenuation of mitochondrial
membranepotential—indicative of impairedmitochondrial
function—under both inflammatory and noninflammatory
conditions in HCA (Fig. 3Ci–Dii).
To further investigate the impact of reduced mito-
chondrial membrane potential on the reparative proper-
ties of HPMECs, mitochondrial membrane potential was
pharmacologically dissipated using the mitochondrial un-
coupler FCCP. Interestingly, FCCP treatment significantly
abrogated HPMEC wound closure (Fig. 3E).
HCA induces mitochondrial dysfunction
in MSCs
Next, the effects ofHCAonhumanbonemarrow–derived
MSCswere tested. Similar to the observations in endothelial
and epithelial cells, HCA did not alter the viability of MSCs
(Fig. 4A). The degree of NF-kB activation (Fig. 4B) and
secretion of Ang-1 and IL-1ra (Fig. 4C, D) were also un-
affected by HCA. Of note, both Ang-1 and IL-1ra are para-
crine soluble factors known to be involved inmediating the
therapeutic effects of MSCs in preclinical models of in-
flammatory lung disease (32, 43). The promotors of both
genes are also under NF-kB regulation (44, 45), further
supporting the finding that the effects of HCA on MSCs
occur independently of alterations to the NF-kB pathway.
Levels of keratinocyte growth factor and IL-10 secreted by
MSCs were also analyzed, but concentrations were below
the lower limits of detection of the assays (,31.25 pg/ml for
both analytes, unpublished results). Again, analogous to its
effect on HPMECs and SAECs, HCA impaired MSC mito-
chondrial function. This was evidenced by attenuated mi-
tochondrial membrane potential (Fig. 4Ei, ii) and reduced
ATP production by the MSCs (Fig. 4F). To buffer the me-
dium pH to that of normocapnia, 0.02 M NaHCO3 was
added to the medium under hypercapnic conditions. This
did not alter the effect of HCA on MSC mitochondrial
membrane potential (Fig. 4G).
HCA-induced mitochondrial dysfunction
impairs the capacity of MSCs to improve
epithelial wound closure
Next, the effect of HCA on the ability of MSCs to improve
SAEC wound closure was investigated. In an in vitro
Figure 2. HCA attenuates wound repair by HPMECs and SAECs. Monolayers of HPMECs and SAECs were wounded in an in vitro
scratch assay and exposed to normocapnia or HCA for 24 h. A) HCA signiﬁcantly reduced percentage wound closure by HPMECs
at 24 h in a noninﬂammatory (vehicle) but not inﬂammatory (cytomix) environment. These ﬁndings are corroborated by
representative images depicting approximate wound areas at 0 and 24 h (n = 4 per group). B) HCA signiﬁcantly reduced
percentage wound closure by SAECs at 24 h in a noninﬂammatory (vehicle) but not inﬂammatory (cytomix) environment. These
ﬁndings are corroborated by representative images depicting approximate wound areas at 0 and 24 h (n = 5 per group). Images
were taken by Zeiss Axiovert 25 CFL microscope. +ve Ctrl, positive control. Box and whisker plots show median, ﬁrst and third
quartiles, and maximum and minimum values. Original magniﬁcation, 320. *P , 0.05, **P , 0.01.
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wound scratch assay, the degree of SAEC wound clo-
sure was significantly enhanced by a noncontact coculture
(Transwell) with MSCs in normocapnia. This effect was at-
tenuated byHCA (Fig. 5Ai, ii). Staining of the same SAECs
for the proliferationmarker Ki67 revealed that the degree of
SAEC proliferation was not altered byMSCs (Fig. 5B).
Given thatMSC secretion of soluble mediators was not
affected by HCA, it was hypothesized that HCA-induced
mitochondrial dysfunction could play a role in the loss
of the MSC effect on epithelial repair. Previous studies
demonstrated that transfer of mitochondria within
extracellular vesicles is important for the therapeutic
mechanism of MSCs in LPS-induced lung injury (36, 46).
To test this hypothesis, the ability to detect MSC mito-
chondria within SAECs after incubation with MSC con-
ditioned medium (CM) was investigated. MSCs were
prestained with MitoTracker Green. Their CM was col-
lected and added to SAECs, which had been prestained
with MitoTracker Red FM. Fluorescence microscopy af-
ter 24-h culture of SAECs with CM revealed evidence
of colocalization of MSC-derived mitochondria with en-
dogenousmitochondriaofSAECs (Fig. 6A, yellowstaining,
white arrows). No difference in the extent ofmitochondrial
transfer between normocapnic andhypercapnic conditions
was observed.
Consistent with the above observations demonstrating
a detrimental effect of HCA on mitochondrial membrane
potential across all 3 cell types studied, HCA significantly
reduced ATP production by SAECs (Fig. 6B). Addition-
ally, whereas MSC-CM enhanced ATP production by
SAECs in normocapnia (albeit nonsignificantly), ATP
levelswere not restoredbyMSC-CMin the setting ofHCA
(Fig. 6B).
To further investigate the requirement of functional
mitochondria for the ability of MSCs to promote SAEC
woundrepair, the in vitro scratchassaywas repeatedusing
MSCs in which mitochondrial dysfunction had been in-
duced by pretreatment with R6G. R6G irreversibly im-
pairs oxidative phosphorylation but does not significantly
impair MSC secretion of soluble mediators (36). Although
MSCs promoted SAEC wound closure in normocapnia,
this effectwas lostwithR6G-pretreatedMSCs (Fig. 6Ci, ii).
DISCUSSION
Low tidal volume ventilation is the mainstay of treat-
ment in ARDS, but it can be associated with the develop-
ment of HCA (2). The capillary endothelium and alveolar
epithelium are key targets in the pathogenesis of ARDS;
Figure 3. HCA does not alter the degree of cytomix-induced NF-kB activation but impairs mitochondrial function. A) When
assessed based on the relative quantity of active p65 subunits present in nuclear extracts from HPMECs, HCA did not affect the
degree of cytomix-induced NF-kB activation at 30 or 60 min (n = 3 per group). B) The degree of cytomix-induced NF-kB
activation in SAECs was also unaffected by HCA at 30 and 60 min when assessed in the same way (n = 5 per group). Ci, ii) Staining
with the mitochondrial membrane potential indicator JC-1 revealed signiﬁcant attenuation of HPMEC mitochondrial membrane
potential by HCA in both the presence and absence of cytomix stimulation at 24 h (n = 5 per group). Ci) Representative images.
Cii) The JC-1 red (aggregate)/green (monomer) ratio was quantiﬁed in ImageJ and presented relative to unstimulated cells in
normocapnia. Di, ii) Mitochondrial membrane potential in SAECs was also attenuated by HCA at 24 h (n = 4 per group). Di)
Representative images. Dii) The JC-1 red (aggregate)/green (monomer) ratio was quantiﬁed in ImageJ and presented relative to
unstimulated cells in normocapnia. E) Wound repair by HPMECs at 24 h was impaired by pharmacological dissipation of
mitochondrial membrane potential using the mitochondrial uncoupler FCCP (n = 3 per group). Images were taken on an EVOS
FL Auto epiﬂuorescence microscope (n = 5 per group). Ctrl, control; ns, not signiﬁcant; OD, optical density; +ve, positive control.
Error bars (A, B) represent SD, and box and whisker plots show median, ﬁrst and third quartiles, and maximum and minimum
values. Original magniﬁcation, 320. A value of P . 0.05 was not signiﬁcant, *P , 0.05, **P , 0.01, ***P , 0.001.
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Figure 4. HCA induces mitochondrial dysfunction in MSCs. A) Viability of MSCs was unaffected by HCA at 24 h when assessed by
measurement of LDH release (n = 2 per group). B) The degree of cytomix-induced NF-kB activation in MSCs was unaffected by HCA at 30
or 60 min when assessed based on the relative amount of active p65 subunits present in nuclear extracts obtained from MSCs (n = 5 per
group for 0 and 60min; n = 4 per group for 30 min). C) MSC secretion of the soluble mediator Ang-1 was not altered by HCA at 24 h when
quantiﬁed by ELISA (n = 5 per group). D) The quantity of the soluble mediator IL-1ra secreted by MSCs was also unaffected by HCA at 24 h
(n = 5 per group). Ei, ii) Staining with the mitochondrial membrane potential indicator JC-1 revealed signiﬁcant attenuation of HPMEC
mitochondrial membrane potential by HCA in both the presence and absence of cytomix stimulation at 24 h. Ei) Representative images.
(continued on next page)
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restoration of their structure and function is required for
resolution of the condition. To date, the effects of HCA on
the pulmonary capillary endothelium are unclear, although
many investigations into its effects on the alveolar epithe-
liumhavebeen limited to cell lines suchasA549.The current
studydemonstrates theeffectsofHCAonprimaryHPMECs
and the SAECs, using a degree of hypercapnia equivalent to
pCO2 9.0 kPa (68 mmHg). This degree of hypercapnia is
believed to be clinically relevant,with a recent observational
studyhavingdemonstrated that 13%of patientswithARDS
develop severe hypercapnia of.60 mmHg.
The main findings from this study are as follows:
1) HCA attenuates inflammatory responses in pri-
mary HPMECs and distal lung epithelial cells while it
simultaneously impairs their reparative capacities (Figs. 1
and 2); 2) HCA induces mitochondrial dysfunction in
primary human pulmonary endothelial and epithelial
cells aswell as bonemarrow–derivedMSCs (Figs. 3 and4);
and 3), whereas MSCs improve epithelial wound closure
through transfer of functional mitochondria within extra-
cellularvesicles,HCA-inducedmitochondrialdysfunction
diminishes the therapeutic effect of MSCs on epithelial
wound repair in the inflammatory environment (Figs. 5
and 6).
Neutrophils are key mediators of inflammation and,
subsequently, tissue damage in ARDS. Their alveolar re-
cruitment depends in part on chemotactic stimuli such as
CXCL5 and CXCL8 (47). In the present study, secretion of
Figure 5. MSCs promote SAEC wound repair in normocapnia but not HCA. Ai, ii) MSCs in a noncontact (Transwell) coculture
with SAECs that had been wounded in an in vitro scratch assay promoted SAEC wound closure in normocapnia. This effect was
not observed in HCA at 24 h (n = 4 per group). B) Wounded SAECs that had been cultured with MSCs in a noncontact coculture
were immunoﬂuorescently stained for the proliferation marker Ki67. Imaging revealed no difference in proliferation across any
of the conditions investigated (n = 3 per group). Images were taken by Zeiss Axiovert 25 CFL microscope Ai) Representative
images. Aii) Percentage of wound closure over 24 hours was quantiﬁed for each condition. Aii, B) Box and whisker plots (Aii)
show median, ﬁrst and third quartiles, and maximum and minimum values; scatter plots (B) show mean and SD. Original
magniﬁcation, 320. *P , 0.05.
Eii) The JC-1 red (aggregate)/green (monomer) ratio was quantiﬁed in ImageJ and presented relative to unstimulated cells in
normocapnia (n = 5 per group). F) HCA attenuated ATP production by MSCs at 24 h (n = 5 per group). G) Buffering medium
pH to that of normocapnia using 0.02 M NaHCO3 did not alter the effect of HCA on mitochondrial membrane potential in MSCs
at 24 h (n = 3 per group except FCCP and all groups not stimulated with cytomix in HCA, which are n = 2). Images were taken on
an EVOS FL Auto epiﬂuorescence microscope. Ctrl. Control; ns, not signiﬁcant; OD, optical density; +ve, positive control. Scatter
plots show mean and SD, and box and whisker plots show median, ﬁrst and third quartiles, and maximum and minimum values.
Original magniﬁcation, 320. *P , 0.05, **P , 0.01, ***P , 0.001.
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these chemokines by both HPMECs and SAECs was at-
tenuated in HCA (Fig. 1). These data are in accordance
with previous in vitro observations using macrovascular
endothelial cells (4) and A549 cells (14), but this is the first
report of the effects of HCA on CXCL5 secretion by
HPMECs and SAECs.
Endothelial expression of neutrophil adhesion mole-
cules also contributes to alveolar neutrophil recruitment.
Although there were no differences in the percentage of
cells expressing adhesionmolecules ICAM-1, VCAM-1, or
E-selectin, the degree of surface expression of ICAM-1
(reflected in theMFI)was significantly attenuated inHCA.
This finding is again in keeping with previous observa-
tions in macrovascular endothelial cells (4).
Attenuated neutrophilia in HCA has been demon-
strated in numerous in vivo studies (11, 12, 48). Data
from the current study suggest that the epithelium and
endothelium contribute to this response by attenuating
neutrophil chemoattraction and migration across the
endothelial-epithelial barrier.
Figure 6. Impaired mitochondrial transfer mediates the loss of MSC therapeutic potential. A) Mitochondria within MSCs were stained with
MitoTracker Green, whereas mitochondria within SAECs were labeled with MitoTracker Red. Stained MSCs were cultured in a noncontact
(Transwell) coculture with stained SAECs. Mitochondrial transfer from MSCs to SAECs was observed by ﬂuorescence microscopy at 24 h.
Representative images. B) Coculture was repeated using unstained cells. MSCs induced a small, albeit insigniﬁcant, increase in ATP
production at 24 h under conditions of normocapnia but not HCA (n = 3 per group). Ci, ii) MSCs were pretreated with R6G to induce
mitochondrial dysfunction. These MSCs were cultured in a noncontact coculture with SAECs that had been wounded in an in vitro
scratch assay. Untreated but not R6G-treated MSCs enhanced SAEC wound closure at 24 h in normocapnia. Ci) Representative images.
Cii) Percentage of wound closure over 24 hours was quantiﬁed for each condition (n = 5–6 per group). Fluorescent images were taken
on an EVOS FL Auto epiﬂuorescence microscope, epithelial wounds (Ci) were imaged by Zeiss Axiovert 25 CFL microscope. Scatter
plots (B) show mean and SD, and box and whisker plots (Cii) show median, ﬁrst and third quartiles, and maximum and minimum
values. Original magniﬁcation, 320. **P , 0.01, ***P , 0.001.
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Integrity of the epithelial and endothelial barriers are key
to regulating neutrophil recruitment, particularly in ARDS,
where basement membranes are often denuded. Following
cell activation, cytoskeletal remodeling occurs, promoting
cell migration in an attempt to restore barrier integrity. In
vitrowoundscratch assays revealed thatHCAsignificantly
impaired wound repair in a noninflammatory environ-
ment and demonstrated a trend toward furtherworsening
in an inflammatory setting (Fig. 2). These findings contrast
with a previous report in which endothelial wound repair
was not altered by HCA (49), although this discrepancy
may be explained by the use of macrovascular endothelial
cells. The findings in SAECs, however, corroborate and
extend previous observations by O’Toole et al. (15).
Surprisingly, although altered NF-kB activation has con-
sistently been attributed to the effects of HCA (14, 15), the
results of the current study suggest that HCA-induced
alterations in inflammatory responses and wound repair oc-
curred independently of NF-kB. To date, impaired mito-
chondrial function is the only alternative mechanism shown
to mediate HCA-driven effects (42). In the current study,
HCA induces significant attenuation of mitochondrial
membrane potential in all 3 primary cell types studied, in-
dicating mitochondrial dysfunction (Figs. 3 and 4). Previous
work has linked alterations in mitochondrial membrane po-
tential with the development of an anti-inflammatory phe-
notype in macrophages (50). In addition, lowmitochondrial
membrane potential has been associated with the induction
ofmitophagy (51, 52).Mitophagyhasbeen reported to confer
resistance to cell death in both alveolar epithelial cells and
macrophages (53, 54), suggesting thatHCAmaybe inducing
mitophagy to maintain cell viability in this study. Low mi-
tochondrial membrane potential and mitophagy have also
been previously associated with impaired proliferation and
migration (55–57), 2 factors contributing to dysregulated tis-
sue repair in ARDS. In the present study, pharmacological
inhibition of mitochondrial membrane potential resulted in
significant abrogation of HPMEC wound closure (Fig. 3E),
suggesting that functional mitochondria are important for
endothelial repair. Thus, HCA-induced mitochondrial dys-
function could negatively affect the reparative capacity of the
injured lung in the clinical setting.
From a therapeutic perspective, although MSCs are a
promising candidate for ARDS (58), their efficacy has never
been studied in the setting of HCA. It is well established that
MSCs secrete a plethora of soluble factors, including Ang-1
and IL-1ra, which are thought tomediate, at least in part, the
therapeutic effects of MSCs (34). The current study demon-
strates that MSC secretion of these NF-kB–regulated mole-
culeswasunalteredbyHCA.Thedegreeof cytomix-induced
NF-kB activation was also unaffected, suggesting that in
HCA MSCs retain their capacity to exert therapeutic effects
mediated by these soluble factors (Fig. 4B–D). Nevertheless,
the therapeutic effect of MSCs on pulmonary epithelial
wound repair was abrogated in HCA [despite MSCs pro-
moting SAEC wound closure via enhanced migration in
normocapnia, aspreviously reported inAkram et al. (59) (Fig.
5).The lackof therapeutic effect ofMSCsmaybeattributed to
impaired mitochondrial function in the presence of HCA.
This was reflected by attenuation of both mitochondrial
membrane potential and intracellular ATP production (Fig.
4Ei–F). Importantly, buffering of acidosis did not alter the
effects of HCA on MSC mitochondrial membrane potential
(Fig. 4G), suggesting that this effect occurs independently of
pH. This HCA-induced mitochondrial damage in MSCs
suggests that MSCs may lose their capacity to improve epi-
thelial repair in patients with ARDSwho develop HCA.
Mitochondrial transfer to surrounding injured cells has
previously been shown to be important for the therapeutic
potential of MSCs (35, 36, 53, 54). Here, mitochondrial
transfer from MSCs to SAECs was observed in both nor-
mocapniaandHCAandwasassociatedwith enhancedATP
production by SAECs in normocapnia (Fig. 6A, B). To in-
vestigatewhethermitochondrial transferwas responsible for
theMSC-mediated improvement in SAECwound closure in
normocapnia, the in vitrowound scratch assaywas repeated
using MSCs with dysfunctional mitochondria. To achieve
this, MSCs had been pretreated with R6G, which induces
mitochondrial dysfunction without significantly affecting
other aspects of cell biology, such as the ability to secrete
soluble molecules (36, 60). The results demonstrate, for the
first time, that functional mitochondria are required for the
ability of MSCs to promote primary human distal lung epi-
thelial repair (Fig. 6Ci, ii). This reveals a new mechanism of
the therapeutic effects of MSCs in ARDS and implies that
HCA-induced mitochondrial dysfunction was responsible
for loss of theMSCeffect in thismodel.Given that transfer of
functional mitochondria was previously shown to be re-
sponsible for MSC modulation of both the phenotype of al-
veolar macrophages (35, 36) and of surfactant secretion by
alveolar epithelial type II cells (46) in preclinical models of
ARDS, this finding raises significant concerns regarding the
therapeutic efficacy of MSCs in patients with HCA.
Although this study provides novel results in relation to
HCA-mediated mitochondrial damage in human pulmo-
nary epithelial and endothelial cells aswell asMSCs, further
investigations into themechanismsof thiseffectare required.
Also, althougha role formitochondrialdysfunction inHCA-
induced inhibition of wound repair was demonstrated, the
mechanism responsible for the anti-inflammatory effect ob-
served inprimary cells inHCAremains unclear. Finally, use
of a broader range of clinically relevant models utilizing
human lung tissues (e.g., ex vivo perfused lungs, lung-on-a-
chip, or precision-cut lung slices) will facilitate better un-
derstanding of the impact of HCA on human lung repair.
DespiteHCAexerting ananti-inflammatory effect, it also
appears to attenuate the reparative capacity of pulmonary
endothelial and epithelial cells and reduce the therapeutic
efficacy of MSCs in ARDS. This suggests that when inter-
preting clinical trial data, a priori post hoc analysis of data
frompatientswith andwithoutHCAmay be useful, as any
protective benefit of anMSC-based therapymaybemasked
by the lack of an effect in patients with HCA. This may
subsequently allow for appropriate stratification of patients
with ARDS who are most likely to respond to MSC-based
therapies.
There are undoubtedly a number of limitations to the
workpresented. For example,whereasaprevious report (61)
suggestedthat theeffectsofhypercapniaonNF-kBactivation
are rapidly reversible, the current studydoes not address the
potential reversibility of the effects of HCA on the anti-
inflammatory and reparative capacities of HPMECs and
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SAECs or on the therapeutic potential of MSCs in ARDS. If
the effects ofHCAare found to be reversible, it is perceivable
that extracorporeal CO2 removal could potentially manage
the effects in patients with ARDS. However, although this
may benefit the impaired therapeutic capacity of MSCs,
which appears to result from HCA, it will undoubtedly be
difficult to achieve a perfect balance between the effects of
HCA on the inflammatory and reparative capacities of
HPMECs and SAECs.
In summary,HCA-inducedmitochondrial dysfunction
may contribute to impaired epithelial and endothelial re-
pair, resulting in worse outcomes for patients with severe
lung disease. Additionally, patientswithHCAmay not be
responsive to treatment with MSCs.
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